Atherosclerosis risk factors in male patients qualified for percutaneous stenting of lower extremity arteries. A retrospective cohort study
DOI:
https://doi.org/10.12775/MBS.2016.012Keywords
peripheral artery disease, lower limb ischemia, atherosclerosis risk factors, epidemiological studiesAbstract
Objectives. Leg ischemia is the third leading cause of atherosclerotic cardiovascular morbidity, concerning about 20-30% of the elderly population. Recognition of its risk factors helps in early diagnosis and patient management. The aim of this study was to determine the prevalence of respective atherosclerosis risk factors among patients with peripheral artery disease (PAD) referred for lower limb endovascular revascularization and compare their prevalence with the data obtained in large epidemiological investigations and in patients with atherosclerosis manifestation in coronary and cerebral vascular beds.
Material and methods. Medical documentation for 73 male patients with PAD after a first endovascular intervention was evaluated retrospectively, and the prevalence of atherosclerosis risk factors found was compared with historical control groups from the literature.
Results. The patients studied presented significantly greater prevalence of a current smoking habit and diabetes mellitus than in the POLSCREEN, WOBASZ and NATPOL PLUS studies, significantly greater prevalence of hypertension than in WOBASZ and NATPOL PLUS, significantly greater prevalence of dyslipidemia than in POLSCREEN and NATPOL PLUS, significantly lower prevalence of BMI ≥ 25 kg/m2 than in POLSCREEN, and greater than in NATPOL PLUS. In comparison to patients with coronary artery disease (CAD), individuals with PAD had a lower prevalence of hypertension and overweight and/or obesity, but greater occurrence of a current smoking habit and dyslipidemia.
Conclusions. Patients with PAD who were qualified for endovascular therapy presented greater prevalence of atherosclerosis risk factors and multisite vascular disease manifestation than various general Polish populations and subjects with CAD, which suggests the need for the improved management of these patients.References
Cantú-Brito C, Chiquete E, Ruiz-Sandoval JL, et al. Atherothrombotic disease, traditional risk factors, and 4-year mortality in a Latin American population: the REACH Registry. Clin Cardiol. 2012;35(8):451-7. doi: 10.1002/clc.22005.
Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329-40. doi: 10.1016/S0140-6736(13)61249-0.
Bartuś S, Siudak Z, Brzeziński M, et al. Percutaneous peripheral interventions in patients with multivessel coronary artery disease. Kardiol Pol. 2010;68(10):1115-21.
Norgren L, Hiatt WR, Dormandy JA, TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67.
European Stroke Organisation, Tendera M, Aboyans V, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851-906. doi: 10.1093/eurheartj/ehr211.
Perk J, De Backer G, Gohlke H, et al. European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635-701. doi: 10.1093/eurheartj/ehs092.
Jang SY, Ju EY, Cho SI, et al. Comparison of cardiovascular risk factors for peripheral artery disease and coronary artery disease in the Korean population. Korean Circ J. 2013;43(5):316-28. doi: 10.4070/kcj.2013.43.5.316.
Poredoš P, Jezovnik M, Kalodiki E, et al. Medical management of patients with peripheral arterial disease. Int Angiol. 2015;34(1):75-93.
Ahn S, Park YJ, Min SI, et al. High prevalence of peripheral arterial disease in Korean patients with coronary or cerebrovascular disease. J Korean Med Sci. 2012;27(6):625-9.
Bez LG, Navarro TP. Study of carotid disease in patients with peripheral artery disease. Rev Col Bras Cir. 2014;41(5):311-8. doi: 10.3346/jkms. 2012.27.6.625.
Naderi N, Masoomi H, Mozaffar T, Malik S. Patient characteristics and comorbidities associated with cerebrovascular accident following acute myocardial infarction in the United States. Int J Cardiol. 2014;175(2):323-7. doi: 10.1016/j.ijcard.2014.05.024.
Kojima I, Ninomiya T, Hata J, et al. A low ankle brachial index is associated with an increased risk of cardiovascular disease: the Hisayama study. J Atheroscler Thromb. 2014;21(9):966-73.
Gronewold J, Hermann DM, Lehmann N, et al. Ankle-brachial index predicts stroke in the general population in addition to classical risk factors. Atherosclerosis. 2014;233(2):545-50. doi: 10.1016/j.atherosclerosis. 2014.01.044.
Imori Y, Akasaka T, Ochiai T, et al. Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease. Am J Cardiol. 2014;113(1):30-5. doi: 10.1016/j.amjcard.2013.09.015.
Aiman U, Haseen MA, Beg MH, et al. Profile of atherosclerotic risk factors and management in patients of peripheral arterial disease at a tertiary care teaching hospital of north India. Indian J Pharm Sci. 2014;76(6):504-9.
Cieśliński A, Pająk A, Podolec P, Rynkiewicz A (red.): Ogólnopolski Program Prewencji Choroby Wieńcowej POLSCREEN. 1st edition, Poznań, Termedia Wydawnictwo Medyczne; 2006, p: 32-38, 49, 59-64, 71, 81-84.
Gąsior M, Pres D, Gierlotka M, et al. The influence of diabetes on in-hospital and long-term mortality in patients with myocardial infarction complicated by cardiogenic shock: results from the PL-ACS registry. Kardiol Pol.2012;70(12):1215-24.
Sielski J, Janion-Sadowska A, Sadowski M, et al. Differences in presentation, treatment, and prognosis in elderly patients with non‑ST‑segment elevation myocardial infarction. Pol Arch Med Wewn. 2012;122(6):253-61.
Gierlotka M, Gąsior M, Tajstra M, et al. Outcomes of invasive treatment in very elderly Polish patients with non-ST-segment-elevation myocardial infarction from 2003-2009 (from the PL-ACS registry). Cardiol J. 2013;20(1):34-43. doi: 10.5603/CJ.2013.0007.
Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478-86. doi: 10.1056/NEJMoa1313600.
Agarwal AK, Singh M, Arya V, et al. Prevalence of peripheral arterial disease in type 2 diabetes mellitus and its correlation with coronary artery disease and its risk factors. J Assoc Physicians India. 2012;60:28-32.
Endo M, Kumakura H, Kanai H, et al. Prevalence and risk factors for renal artery stenosis and chronic kidney disease in Japanese patients with peripheral arterial disease. Hypertens Res. 2010;33(9):911-5. doi: 10.1038/hr.2010.93.
Sumner AD, Khalil YK, Reed JF 3rd. The relationship of peripheral arterial disease and metabolic syndrome prevalence in asymptomatic US adults 40 years and older: results from the National Health and Nutrition Examination Survey (1999-2004). J Clin Hypertens (Greenwich). 2012;14(3):144-8. doi: 10.1111/j.1751-7176.2011.00580.x.
Yu JH, Hwang JY, Shin MS, et al. The prevalence of peripheral arterial disease in Korean patients with type 2 diabetes mellitus attending a university hospital. Diabetes Metab J. 2011;35(5):543-50. doi: 10.4093/dmj. 2011.35.5.543.
Aboyans V, McClelland RL, Allison MA, et al. Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2011;214(1):169-73. doi: 10.1016/j.atherosclerosis. 2010.10.011.
Satiroglu O, Kocaman SA, Karadag Z, et al. Relationship of the angiographic extent of peripheral arterial disease with coronary artery involvement. J Pak Med Assoc. 2012;62(7):644-9.
Radak D, Babic S, Peric M, et al. Distribution of risk factors in patients with premature coronary, supra-aortic branches and peripheral atherosclerotic disease. Med Princ Pract. 2012;21(3):228-33. doi: 10.1159/000334617.
Agarwal S, Naderi S. Etiopathogenic differences in coronary artery disease and peripheral artery disease: results from the National Health and Nutrition Examination Survey. Angiology. 2014;65(10):883-90. doi: 10.1177/0003319713509303.
Veenstra RP, ter Steege RW, Geelkerken RH, et al. The cardiovascular risk profile of atherosclerotic gastrointestinal ischemia is different from other vascular beds. Am J Med. 2012;125(4):394-8. doi: 10.1016/j.amjmed.2011.09.013.
Pająk A, Szafraniec K, Janion M, et al. The impact of the Polish national Programme of Cardiovascular Disease Prevention on the quality of primary cardiovascular disease prevention in clinical practice. Kardiol Pol. 2010;68(12):1332-40.
Alvarez LR, Balibrea JM, Suriñach JM, et al. Smoking cessation and outcome in stable outpatients with coronary, cerebrovascular, or peripheral artery disease. Eur J Prev Cardiol. 2013;20(3):486-95. doi: 10.1177/1741826711426090.
Hussein AA, Uno K, Wolski K, et al. Peripheral arterial disease and progression of coronary atherosclerosis. J Am Coll Cardiol. 2011;57(10):1220-5. doi: 10.1016/j.jacc.2010.10.034.
Antoniou GA, Fisher RK, Georgiadis GS, et al. Statin therapy in lower limb peripheral arterial disease: Systematic review and meta-analysis. Vascul Pharmacol. 2014;63(2):79-87. doi: 10.1016/j.vph.2014.09.001.
Galiñanes EL, Reynolds S, Dombrovskiy VY, Vogel TR. The impact of preoperative statin therapy on open and endovascular abdominal aortic aneurysm repair outcomes. Vascular. 2014;Oct 14. pii: 1708538114552837.
Markel A. Statins and peripheral arterial disease. Int Angiol. 2014;
Suckow BD, Kraiss LW, Schanzer A, et al. Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival. J Vasc Surg. 2015;61(1):126-133.e1. doi: 10.1016/j.jvs.2014.05.093.
Dosluoglu HH, Davari-Farid S, Pourafkari L, et al.. Statin use is associated with improved overall survival without affecting patency and limb salvage rates following open or endovascular revascularization. Vasc Med. 2014;19 (2):86-93.
Sohn MW, Meadows JL, Oh EH, et al. Statin use and lower extremity amputation risk in nonelderly diabetic patients. J Vasc Surg. 2013;58(6):1578-1585.e1. doi: 10.1016/j.jvs.2013.06.069.
Aiello FA, Khan AA, Meltzer AJ, et al. Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia. J Vasc Surg. 2012;55(2):371-9. doi: 10.1016/j.jvs.2011.08.044.
Downloads
Published
How to Cite
Issue
Section
Stats
Number of views and downloads: 220
Number of citations: 0